(Q33752523)

29 July 2017

1 reference

title

The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX). (English)

1 reference

29 July 2017

1 reference

1 reference

Giverhaug T

1

1 reference

29 July 2017

Loennechen T

series ordinal

2

1 reference

29 July 2017

Aarbakke J

series ordinal

3

1 reference

29 July 2017

publication date

1 October 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

33

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

341-346

1 reference

The cell cycle and induction of apoptosis in a hamster fibrosarcoma cell line treated with anti-cancer drugs: its importance to solid tumour chemotherapy

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

The effect of methotrexate on the bioavailability of oral 6-mercaptopurine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

Methotrexate increases red blood cell concentrations of 6-methylmercaptopurine ribonucleotide in rats in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

Increased concentrations of methylated 6-mercaptopurine metabolites and 6-thioguanine nucleotides in human leukemic cells in vitro by methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2899%2900022-1

7 January 2021

10.1016/S0306-3623(99)00022-1

Identifiers

DOI

1 reference

29 July 2017

1 reference